ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
NCT00616460
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Diseases
Interventions
DRUG:
Bivalirudin
Sponsor
HaEmek Medical Center, Israel